Ductal Carcinoma In Situ of the Breast With Close or Focally Involved Margins Following Breast-Conserving Surgery: Treatment With Reexcision or Radiotherapy With Increased Dosage

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1021-1028

  Monteau, Amélie ^a   Sigal Zafrani, Brigitte ^a   Kirova, Youlia M ^a   Fourchotte, Virginie ^a   Bollet, Marc A ^a   Vincent Salomon, Anne ^a   Asselain, Bernard ^a   Salmon, Remy J ^a   Fourquet, Alain ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CONSERVING SURGERY; BREAST IRRADIATION; DUCTAL CARCINOMA IN SITU; FAILURE RATE; HISTOLOGICAL FEATURES; LOCAL CONTROL; MARGIN STATUS; RADIATION DOSE; TOTAL DOSE;

DOSIMETRY; FLUORINE CONTAINING POLYMERS; IRRADIATION; PHOTOTRANSISTORS; SURGERY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; BREAST TUMOR; DISEASE FREE SURVIVAL; METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REOPERATION; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449721901     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.014     Document Type: Article

References (34)

1. Ernster V.L., Barclay J., Kerlikowske K., et al. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160 (2000) 953-958
2. Bijker N., Meijnen P., Peterse J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized Phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 (2006) 3381-3387
3. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28 (2001) 400-418
4. Holmberg L., Garmo H., Granstrand B., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26 (2008) 1247-12452
5. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 362 (2003) 95-102
6. Solin L.J., Fourquet A., Vicini F.A., et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103 (2005) 1137-1146
7. Kestin L.L., Goldstein N.S., Lacerna M.D., et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer 88 (2000) 596-607
8. Cutuli B., Cohen-Solal-le Nir C., de Lafontan B., et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: The French Cancer Centers' experience. Int J Radiat Oncol Biol Phys 53 (2002) 868-879
9. Vicini F.A., and Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: A critical review of the literature. J Clin Oncol 20 (2002) 2736-2744
10. Vargas C., Kestin L., Go N., et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 63 (2005) 1514-1521
11. Solin L.J., Fowble B.L., Schultz D.J., and Goodman R.L. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21 (1991) 279-287
12. The American College of Surgeons. Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS). J Am Coll Surg 205 (2007) 145-161
13. Olivotto I., and Levine M. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). CMAJ 165 (2001) 912-913
14. Cutuli B., Fourquet A., Luporsi E., et al. [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. Bull Cancer 92 (2005) 155-168
15. Luini A, Rososchansky J, Gatti G, et al. The surgical margin status after breast-conserving surgery: Discussion of an open issue (Epub ahead of print April 4, 2008). Breast Cancer Res Treat.
16. Jones H.A., Antonini N., Collette L., et al. The impact of boost dose and margins on the local recurrence rate in breast conserving therapy: Results from the EORTC Boost-No Boost Trial. Proceedings of the ASTRO's 49th Annual Meeting; 2007 Oct 28-Nov 1; Los Angeles, CA. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) S2-S3
17. Sigal-Zafrani B., Lewis J.S., Clough K.B., et al. Histological margin assessment for breast ductal carcinoma in situ: Precision and implications. Mod Pathol 17 (2004) 81-88
18. The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 80 (1997) 1798-1802
19. Fourquet A., Campana F., Rosenwald J.C., and Vilcoq J.R. Breast irradiation in the lateral decubitus position: Technique of the Institut Curie. Radiother Oncol 22 (1991) 261-265
20. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
21. Cox D.R. Regression models and life-tables. J Royal Stat Soc Series B 34 (1972) 187-220
22. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: Intraductal carcinoma. Cancer 86 (1999) 429-438
23. Omlin A., Amichetti M., Azria D., et al. Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 7 (2006) 652-656
24. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
25. Romestaing P., Lehingue Y., Carrie C., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 15 (1997) 963-968
26. Vincent-Salomon A., Lucchesi C., Gruel N., et al. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin Cancer Res 14 (2008) 1956-1965
27. Anscher M.S., Jones P., Prosnitz L.R., et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218 (1993) 22-28
28. Jobsen J.J., van der Palen J., Ong F., and Meerwaldt J.H. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 57 (2003) 724-731
29. Wazer D.E., Schmidt-Ullrich R.K., Ruthazer R., et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 40 (1998) 851-858
30. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18 (2000) 1668-1675
31. DiBiase S.J., Komarnicky L.T., Heron D.E., et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phy 53 (2002) 680-686
32. Neuschatz A.C., DiPetrillo T., Steinhoff M., et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 94 (2002) 1917-1924
33. Dillon M.F., Mc Dermott E.W., O'Doherty A., et al. Factors affecting successful breast conservation for ductal carcinoma in situ. Ann Surg Oncol 14 (2007) 1618-1628
34. Fourquet A., Sigal-Zafrani B., and Clough K.B. Breast-conserving surgery plus radiation therapy in ductal carcinoma in situ: The Institut Curie experience. In: Silverstein M.J., Recht A., and Lagios M.D. (Eds). Ductal carcinoma in situ of the breast. 2nd ed (2002), Lippincott Williams & Wilkins, Philadelphia 367-372